Pediatric Pulmonary Vascular Disease or Adult Pulmonary Vascular Disease

Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis

Hui Zhao, Lan Wang, Yi Yan, Qin-Hua Zhao, Jing He, Rong Jiang, Ci-Jun Luo, Hong-Ling Qiu, Yu-Qing Miao, Su-Gang Gong, Ping Yuan, Wen-Hui WuShanghai Pulmonary Hospital and Tongji University. University of Shanghai for Science and Technology. Shanghai Children’s Medical Center and Shanghai Jiao Tong University.China Frontiers in ImmunologyFront Immunol 2023; DOI: 10.3389/fimmu.2023.1197752 AbstractPulmonary fibrosis (PF) and […]

Identification of the shared gene signatures between pulmonary fibrosis and pulmonary hypertension using bioinformatics analysis Read More »

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan

Emi Matsugi, Shigeki Takashima, Shuhei Doteguchi, Tomomi Kobayashi, Motohiro OkayasuMallinckrodt Pharmaceuticals. Japan General Thoracic and Cardiovascular SurgeryGen Thorac Cardiovasc Surg 2023; DOI: 10.1007/s11748-023-01971-2 AbstractObjective: To evaluate the real-world safety and effectiveness of inhaled nitric oxide (INOflo® for Inhalation 800 ppm) for perioperative pulmonary hypertension associated with cardiac surgery in Japan.Methods: This was a prospective, non-interventional, all-case, post-marketing study of

Real-world safety and effectiveness of inhaled nitric oxide therapy for pulmonary hypertension during the perioperative period of cardiac surgery: a post-marketing study of 2817 patients in Japan Read More »

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

Marc Humbert, Gabor Kovacs, Marius M. Hoeper, Roberto Badagliacca, Rolf M. F. Berger, Margarita Brida, Jorn Carlsen, Andrew J. S. Coats, Pilar Escribano-Subias, Pisana Ferrari, Diogenes S. Ferreira, Hossein Ardeschir Ghofrani, George Giannakoulas, David G. Kiely, Eckhard Mayer, Gergely Meszaros, Blin Nagavci, Karen M. Olsson, Joanna Pepke-Zaba, Göran Radegran, Gerald Simonneau, Oliver Sitbon, Thomy Tonia,

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension Read More »

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival

Guillermo Torres, Andrew C. Lancaster, Jun Yang, Megan Griffiths, Stephanie Brandal, Rachel Damico, Dhananjay Vaidya, Catherine E. Simpson, Lisa J. Martin, Michael W. Pauciulo, William C. Nichols, D. Dunbar Ivy, Eric D. Austin, Paul M. Hassoun, Allen D. EverettJohns Hopkins University. University of Texas Southwestern Medical Center. Cincinnati Children’s Hospital Medical Center and University of

Low-affinity insulin-like growth factor binding protein 7 and its association with pulmonary arterial hypertension severity and survival Read More »

Congenital and acquired pulmonary vein stenosis

Larry A. Latson, Lourdes R. PrietoCleveland Clinic FoundationUnited States CirculationCirculation 2007; 115: 103-108DOI: 10.1161/CIRCULATIONAHA.106.646166 AbstractNo Abstract Available CategorySegmental Pulmonary Venous Disease. Without a Focus on Pulmonary HypertensionSurgical and Catheter-mediated Interventions for Pulmonary Vascular DiseaseDiagnostic Testing for Pulmonary Vascular Disease. Non-invasive TestingDiagnostic Testing for Pulmonary Vascular Disease. Invasive TestingReview Articles Concerning Pulmonary Vascular Disease Age Focus: Pediatric Pulmonary Vascular Disease

Congenital and acquired pulmonary vein stenosis Read More »

The emerging roles of SUMOylation in pulmonary diseases

Xuyang Zheng, Lingqiao Wang, Zhen Zhang, Huifang TangThe Affiliated Hangzhou First People’s Hospital, Zhejiang Respiratory Drugs Research Laboratory and Zhejiang University School of Medicine. China Molecular MedicineMol Med 2023; 29: DOI: 10.1186/s10020-023-00719-1 AbstractSmall ubiquitin-like modifier mediated modification (SUMOylation) is a critical post-translational modification that has a broad spectrum of biological functions, including genome replication and repair,

The emerging roles of SUMOylation in pulmonary diseases Read More »

Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study

Yu-Nan Huang, Jing-Yang Huang, Wen-Ling Liao, Shang-Lun Chiang, Kai-Wen Liu, Da-Tian Bau, Chung-Hsing Wang, Pen-Hua SuChung Shan Medical University Hospital. China Medical University Hospital. I-Shou University. Children’s Hospital of China Medical University. Taiwan In VivoIn Vivo 2023; 37: 2276-2283DOI: 10.21873/invivo.13330 AbstractBackground/aim: Gaucher disease (GD) is a rare lysosomal storage disorder that can involve the lungs and pulmonary

Incidence of Pulmonary and Respiratory Conditions in Gaucher Disease from 2000 to 2020: A Multi-institutional Cohort Study Read More »

Management of pulmonary arterial hypertension during pregnancy

Kaushiga Krishnathasan, Andrew Constantine, Isma Rafiq, Ana Barradas Pires, Hannah Douglas, Laura C. Price, Konstantinos DimopoulosRoyal Brompton Hospital and Royal Brompton & Harefield Hospitals. Imperial College. St Thomas’ Hospital. King’s College.United Kingdom Expert Review of Respiratory MedicineExpert Rev Respir Med 2023; 17: 413-423DOI: 10.1080/17476348.2023.2210838 AbstractIntroduction: Pulmonary arterial hypertension (PAH) is defined as a mean pulmonary artery pressure

Management of pulmonary arterial hypertension during pregnancy Read More »

Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry

Megan Mayer, David B. Badesch, Kelly H. Nielsen, Steven Kawut, Todd Bull, John J. Ryan, Jeffrey Sager, Sula Mazimba, Anna Hemnes, James Klinger, James Runo, John W. McConnell, Teresa DeMarco, Murali M. Chakinala, Delphine Yung, Jean Elwing, Adolfo Kaplan, Rahul Argula, Raymond Pomponio, Ryan Peterson, Peter HountrasUniversity of Colorado. University of Pennsylvania. University of Utah.

Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry Read More »

Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?

Adele Valentini, Paola Franchi, Giuseppe Cicchetti, Gaia Messana, Greta Chiffi, CeciliaStrappa, Lucio Calandriello, Annemiliadel Ciello, Alessandra Farchione, Lorenzo Preda, Anna Rita LariciFondazione IRCCS Policlinico San Matteo. G. Mazzini Hospital. Fondazione Policlinico Universitario. University of Pavia. Università Cattolica del Sacro Cuore. Italy DiagnosticsDiagnostics 2023; 13: DOI: 10.3390/diagnostics13091607 AbstractPulmonary hypertension (PH) is a pathophysiological disorder, defined by a

Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play? Read More »

Scroll to Top